オンコリスバイオファーマ株式会社 · ONCOLYS BIOPHARMA INC.
Last · Tokyo¥5740.00-50.00 (-0.86%)close · yahoo · 30h ago
Market cap¥169.0B29.4M sh
P/E · TTM-108fwd -76.5 · eps -53.38 · loss
Beta1.19vs S&P 500
Div yield—annual · TTM
52w range
¥601.00¥5970.00
Volume1.7Msession
| Revenue | ¥503.1M |
|---|---|
| Operating income | ¥-767.6M |
| Free cash flow | ¥-1.0B |
| Operating margin | -152.6% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-25
- Operating Cf Burn
- Cash Runway Low
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.8 years
- Rd Intensity High — R&D/Revenue 5150.9%